Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 5/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 4/20 | 0.39 |
| ▸ | HSD17B2 | P37059 | 4/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 2/20 | 0.37 |
| ▸ | CSF1R | P07333 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NSD2 | O96028 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13589319 | 0.94 | ACHE (0.39) | ACHEHSD17B1HSD17B2SIGMAR1EGFR | |
| SCHEMBL10065623 | 0.86 | ACHE (0.42) | ACHEHSD17B1HSD17B2SIGMAR1EGFR | |
| SCHEMBL13589798 | 0.84 | ACHE (0.41) | ACHEHSD17B1HSD17B2SIGMAR1EGFR | |
| SCHEMBL14283658 | 0.84 | HPGD (0.36) | HSD17B1HSD17B2ALDH1A1TDP1TSHR | |
| SCHEMBL766096 | 0.83 | TP53 (0.38) | ACHEHSD17B1HSD17B2EGFRCSF1R | |
| SCHEMBL13826091 | 0.83 | ACHE (0.48) | ACHEHSD17B1HSD17B2SIGMAR1EGFR | |
| SCHEMBL977663 | 0.82 | ACHE (0.58) | ACHEHSD17B1HSD17B2SIGMAR1EGFR | |
| SCHEMBL134721 | 0.80 | ACHE (0.55) | ACHEHSD17B1HSD17B2SIGMAR1EGFR | |
| SCHEMBL29692933 | 0.80 | ACHE (0.55) | ACHEHSD17B1HSD17B2SIGMAR1EGFR | |
| SCHEMBL19473596 | 0.80 | HSD17B1 (0.44) | ACHEHSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9657040-B2 | Cyclic siloxane compound, organic electroluminescence device, and use of the same | SAMSUNG ELECTRONICS CO., LTD (KR) | 2017-05-23 | — | — | US | disclosed |
| US-9657040-B2 | Cyclic siloxane compound, organic electroluminescence device, and use of the same | SAMSUNG ELECTRONICS CO., LTD (KR) | 2017-05-23 | — | — | US | disclosed |
| US-8735875-B2 | Light emitting element, method for manufacturing light emitting element, image display device, and illuminating device | SHOWA DENKO K.K. (JP) | 2014-05-27 | — | — | US | disclosed |
| US-8735875-B2 | Light emitting element, method for manufacturing light emitting element, image display device, and illuminating device | SHOWA DENKO K.K. (JP) | 2014-05-27 | — | — | US | disclosed |
| US-20120267614-A1 | LIGHT EMITTING ELEMENT, METHOD FOR MANUFACTURING LIGHT EMITTING ELEMENT, IMAGE DISPLAY DEVICE, AND ILLUMINATING DEVICE | SHOWA DENKO K.K. (JP) | 2012-10-25 | — | — | US | disclosed |
| US-20120267614-A1 | LIGHT EMITTING ELEMENT, METHOD FOR MANUFACTURING LIGHT EMITTING ELEMENT, IMAGE DISPLAY DEVICE, AND ILLUMINATING DEVICE | SHOWA DENKO K.K. (JP) | 2012-10-25 | — | — | US | disclosed |
| US-20100060150-A1 | CYCLIC SILOXANE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND USE OF THE SAME | SAMSUNG ELECTRONICS CO., LTD (KR) | 2010-03-11 | — | — | US | disclosed |
| US-20100060150-A1 | CYCLIC SILOXANE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND USE OF THE SAME | SAMSUNG ELECTRONICS CO., LTD (KR) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100060150-A1 | CYCLIC SILOXANE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND USE OF THE SAME | TMEM109, EPCAM, TRPM2 | ACHE 1766/4885HSD17B1 4005/4885HSD17B2 4360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.